A Study of CM313 Injection in Subjects With Systemic Lupus Erythematosus

NCT05465707 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

BIOLOGICAL: CM313 2 mg/kg
BIOLOGICAL: CM313 4 mg/kg
BIOLOGICAL: CM313 8 mg/kg
BIOLOGICAL: CM313 16 mg/kg
BIOLOGICAL: Placebo

Sponsor

Keymed Biosciences Co.Ltd